Arrayjet introduces Mercury range of next-generation microarray printers

Arrayjet, a leading provider of inkjet liquid-handling solutions, today introduced Mercury, a new core range of five instruments for ultra-low-volume liquid dispensing. The new print dispensers offer radically improved functionality and reliability, with further enhanced speed and precision. Available in a range of output capacities from 25 to 1000 slides, Mercury instruments can be used for a wide range of microarray and microfluidics applications within pharmaceutical, diagnostic and life science workflows.

  • Enables ultra-low-volume liquid dispensing for new microarray applications including small molecule drug discovery
  • Compacted design, improved functionality, and industry-leading printing speed
  • Available in custom application-specific packages for ease of set-up
  • Manufactured under ISO 13485:2016

Arrayjet’s high-speed microarray printers harness patented, non-contact inkjet technology for printing multiplex array-based assays onto slides, point-of-care devices, biochips and microplates. The technology has the versatility to print any biological sample onto any substrate, at a speed up to 100-times faster than traditional pin-spotting or tip-dispensing systems. Building on five years of research and development, the Mercury range offers cost-effective, higher-throughput arraying with in-line quality control, whilst requiring minimal manual input. These next generation printers encompass the Company’s latest advances, expanding its arraying capabilities into new research areas, such as small molecule drug discovery, autoimmune screening, and multiplex-diagnostics.

The Mercury range is more compact, with even tighter environmental controls for printing consistency. The new design is easier to set-up, use and maintain. In addition, the instruments incorporate a new printhead range for faster and more accurate printing of a larger range of volumes and spot sizes. Advanced capabilities can be custom-tailored or chosen from six application-specific packages comprising printing, scanning, reagents and substrates, enabling users to access the functionalities most relevant for them. Mercury is upgradeable and scalable for growing manufacturing or research requirements, and fully compatible with future developments from Arrayjet.

Over 20 years, Arrayjet has established its reputation as the industry-leading provider of inkjet bioprinting systems. With the launch of Mercury instruments, our offering is stronger than ever. The new range comprises the fastest and highest throughput microarrayers on the market; helping our customers to reduce costs, save time and minimise reagent use” He added: “This range incorporates our multidisciplinary team’s assay development expertise and innovation, alongside valued customer feedback; showcasing Arrayjet’s continued dedication to advancing microarray printing.” 

Dr. Iain McWilliam, Chief Executive Officer of Arrayjet


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Arrayjet Ltd. (2022, April 04). Arrayjet introduces Mercury range of next-generation microarray printers. AZoLifeSciences. Retrieved on May 30, 2024 from

  • MLA

    Arrayjet Ltd. "Arrayjet introduces Mercury range of next-generation microarray printers". AZoLifeSciences. 30 May 2024. <>.

  • Chicago

    Arrayjet Ltd. "Arrayjet introduces Mercury range of next-generation microarray printers". AZoLifeSciences. (accessed May 30, 2024).

  • Harvard

    Arrayjet Ltd. 2022. Arrayjet introduces Mercury range of next-generation microarray printers. AZoLifeSciences, viewed 30 May 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.